GPCR Reporter Cells
Class A, B1 and C receptor models — 130+ targets in CRE-Luc, NFAT-Luc, β-arrestin and Gα15 formats, supplied with validation data and parental-cell controls.
Immunotherapy Cells
Effector and target pairs for checkpoint and combination screening — PD-1, CTLA-4, TIGIT, LAG-3, 4-1BB, OX40 and SIRPα/CD47, with dual-reporter readouts and matched aAPCs.
Other Stable Cells
Pathway reporters — NFκB, STAT, CRE, SRE, NFAT, SBE — plus nuclear receptor, ion channel, transporter and tracer lines, for mechanism, selectivity and safety studies.
Assay Kits & Reagents
Assay-ready kits and matched reagents: detection solutions, media and controls qualified on the same cell models, so results hold from plate to plate and lab to lab.
Stable Cell Line Development
We offer comprehensive solutions for stable cell line generation, including lentiviral integration, Flp-FRT site-specific integration, plasmid random integration, electroporation-based plasmid integration, and transposon-mediated integration.
GPCR Cell-Based Assays
Our GPCR assay services focus on the development, optimization, and validation of robust cellular models. These models are designed to accurately and reproducibly reflect compound-GPCR interactions, providing a reliable foundation for.... high-throughput screening and lead optimization.
Immuno-Oncology Cell Models
We specialize in the development, optimization, and validation of cellular models for immuno-oncology targets. As your strategic partner, we are committed to enhancing your R&D success ...
Kinase Screening Platforms
We provide end-to-end cell-based model development services for kinase-targeted drug screening. Our approach centers on the development, optimization, and validation of kinase assays at the ....
PROTAC Degradation Models
A key challenge in PROTAC development lies in accurately predicting and optimizing degradation efficacy, rather than mere binding affinity. Our PROTAC target model services are ...
ADC Target Cell Models
As ADC drug development advances beyond simple payload delivery, there is a growing need to evaluate differentiated mechanisms of action. Our ADC target model services provide a sophisticated platform for in-depth mechanistic insight.
Molecular Biology Services
We deliver comprehensive and precise molecular biology solutions to support life science research and biopharmaceutical development. Key services include CRISPR-Cas9 sgRNA library synthesis, STR profiling, and quantitative real-time PCR.
Drug Safety & Toxicology
With extensive expertise in in vitro pharmacology, we continuously innovate to meet evolving industry needs. Our integrated evaluation system—spanning cell biology, biochemistry, and molecular biology—provides a complete suite of in vitro ...
Gene Editing Services
Our core services include gene knockdown, knockout, and knock-in, enabling targeted genomic modifications with high accuracy.
EN
Drug Target Models
Services
Resources
Company
Years
October 28, 2026
October 27, 2026
